IRIS
MADEDDU, GIORDANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 633
AS - Asia 442
EU - Europa 431
SA - Sud America 89
AF - Africa 51
OC - Oceania 1
Totale 1.647
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 594
RU - Federazione Russa 251
SG - Singapore 194
IT - Italia 94
CN - Cina 72
BR - Brasile 68
VN - Vietnam 63
BD - Bangladesh 33
KR - Corea 32
FR - Francia 27
CA - Canada 21
CI - Costa d'Avorio 21
NG - Nigeria 18
HK - Hong Kong 13
IN - India 12
MX - Messico 9
GB - Regno Unito 8
AR - Argentina 7
ES - Italia 7
JP - Giappone 7
DE - Germania 6
PL - Polonia 6
FI - Finlandia 5
IQ - Iraq 5
NL - Olanda 5
VE - Venezuela 4
ZA - Sudafrica 4
CL - Cile 3
CO - Colombia 3
ID - Indonesia 3
SE - Svezia 3
UA - Ucraina 3
BG - Bulgaria 2
CR - Costa Rica 2
DK - Danimarca 2
EC - Ecuador 2
EG - Egitto 2
HU - Ungheria 2
IE - Irlanda 2
JM - Giamaica 2
KE - Kenya 2
SN - Senegal 2
UZ - Uzbekistan 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
BE - Belgio 1
BJ - Benin 1
BS - Bahamas 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
LB - Libano 1
MY - Malesia 1
NP - Nepal 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 1.647
Salva come PNG Salva come JPEG
Città #
Dallas 152
Moscow 131
Singapore 131
Santa Clara 90
San Jose 68
Ashburn 51
Los Angeles 38
Seoul 32
Beijing 23
Abidjan 21
Lauterbourg 21
Ho Chi Minh City 20
New York 18
Hefei 17
Abuja 15
Buffalo 13
Hong Kong 13
Rome 13
Rende 12
São Paulo 12
Catania 10
Council Bluffs 10
Hanoi 10
Montreal 7
Tokyo 7
Boston 6
Brooklyn 6
Mexico City 6
Orem 6
Toronto 6
Bologna 5
Denver 5
Houston 5
Warsaw 5
Atlanta 4
Chennai 4
Johannesburg 4
Kochi 4
Lappeenranta 4
Misterbianco 4
Phoenix 4
Bastiglia 3
Chicago 3
London 3
Milan 3
Paris 3
Porto Alegre 3
Salvador 3
San Francisco 3
Santiago 3
Stockholm 3
Amsterdam 2
Austin 2
Bandung 2
Boardman 2
Bắc Giang 2
Calgary 2
Caruaru 2
Copenhagen 2
Da Nang 2
Dublin 2
Guangzhou 2
Gütersloh 2
Haiphong 2
Ipirá 2
Kyiv 2
Madrid 2
Manchester 2
Messina 2
Minneapolis 2
Nairobi 2
Norfolk 2
Nova Friburgo 2
Palermo 2
Parma 2
Port Harcourt 2
Quảng Ngãi 2
San Giovanni la Punta 2
Siena 2
Tashkent 2
Thái Nguyên 2
Turin 2
Abbeville 1
Afragola 1
Agawam 1
Almirante Brown 1
Amman 1
Anápolis 1
Arcoverde 1
Arlington 1
Aswān 1
Baghdad 1
Belo Campo 1
Belo Horizonte 1
Bexley 1
Bismarck 1
Boca Raton 1
Bogotá 1
Bratislava 1
Brockton 1
Totale 1.123
Salva come PNG Salva come JPEG
Nome #
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 146
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 98
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 87
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 87
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results a large multicentre observational prospective cohort (SCOLTA) 86
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 80
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 76
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 75
Factors associated with weight gain in people treated with dolutegravir 71
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 68
Enhanced immunological recovery with early start of antiretroviral therapy during acute or early HIV infection–results of Italian network of acute HIV infection (Inaction) retrospective study 67
Weight gain: A possible side effect of all antiretrovirals 64
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir 61
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: The HIVand Hypertension Study 61
Impact of genotypic susceptibility score on cART outcomes during primary HIV infection 54
Novelties in evaluation and monitoring of human immunodeficiency virus-1 infection: Is standard virological suppression enough for measuring antiretroviral treatment success? 53
Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project) 53
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 53
Efficacy of 1998 Vs 2006 first-line antiretroviral regimens for HIV infection: An ordinary clinics retrospective investigation 53
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals 53
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance 52
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort 46
Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort 46
Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: Results of a nationwide cross-sectional study 43
Efficacy and Safety of Cabotegravir–Rilpivirine in PLWH: A Real-World Study 40
Totale 1.673
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.305
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.305
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20233 0 0 0 0 0 0 0 0 3 0 0 0
2023/20242 0 0 0 0 0 1 0 0 0 0 0 1
2024/2025346 8 7 7 7 93 49 3 12 34 41 33 52
2025/20261.305 59 56 190 98 195 276 107 40 62 96 62 64
2026/202717 17 0 0 0 0 0 0 0 0 0 0 0
Totale 1.673